Liquid biopsy for cancer diagnosis using vibrational spectroscopy: systematic review
Background Vibrational spectroscopy (VS) is a minimally invasive tool for analysing biological material to detect disease. This study aimed to review its application to human blood for cancer diagnosis. Methods A systematic review was undertaken using a keyword electronic database search (MEDLINE, E...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Oxford University Press
2020-08-01
|
| Series: | BJS Open |
| Online Access: | https://doi.org/10.1002/bjs5.50289 |
| _version_ | 1819177585465098240 |
|---|---|
| author | D. J. Anderson R. G. Anderson S. J. Moug M. J. Baker |
| author_facet | D. J. Anderson R. G. Anderson S. J. Moug M. J. Baker |
| author_sort | D. J. Anderson |
| collection | DOAJ |
| description | Background Vibrational spectroscopy (VS) is a minimally invasive tool for analysing biological material to detect disease. This study aimed to review its application to human blood for cancer diagnosis. Methods A systematic review was undertaken using a keyword electronic database search (MEDLINE, Embase, PubMed, TRIP and Cochrane Library), with all original English‐language manuscripts examining the use of vibrational spectral analysis of human blood for cancer detection. Studies involving fewer than 75 patients in the cancer or control group, animal studies, or where the primary analyte was not blood were excluded. Results From 1446 results, six studies (published in 2010–2018) examining brain, bladder, oral, breast, oesophageal and hepatic cancer met the criteria for inclusion, with a total population of 2392 (1316 cancer, 1076 control; 1476 men, 916 women). For cancer detection, reported mean sensitivities in each included study ranged from 79·3 to 98 per cent, with specificities of 82·8–95 per cent and accuracies between 81·1 and 97·1 per cent. Heterogeneity in reporting strategies, methods and outcome measures made meta‐analysis inappropriate. Conclusion VS shows high potential for cancer diagnosis, but until there is agreement on uniform standard reporting methods and studies with adequate sample size for valid classification models have been performed, its value in clinical practice will remain uncertain. |
| first_indexed | 2024-12-22T21:29:00Z |
| format | Article |
| id | doaj.art-dfa5c1ba6dfb4e6bab28faad7a0ae86b |
| institution | Directory Open Access Journal |
| issn | 2474-9842 |
| language | English |
| last_indexed | 2024-12-22T21:29:00Z |
| publishDate | 2020-08-01 |
| publisher | Oxford University Press |
| record_format | Article |
| series | BJS Open |
| spelling | doaj.art-dfa5c1ba6dfb4e6bab28faad7a0ae86b2022-12-21T18:11:58ZengOxford University PressBJS Open2474-98422020-08-014455456210.1002/bjs5.50289Liquid biopsy for cancer diagnosis using vibrational spectroscopy: systematic reviewD. J. Anderson0R. G. Anderson1S. J. Moug2M. J. Baker3WestCHEM, Department of Pure and Applied Chemistry Glasgow UKClinical Research Unit, Royal Alexandra Hospital, NHS Greater Glasgow and Clyde Paisley UKClinical Research Unit, Royal Alexandra Hospital, NHS Greater Glasgow and Clyde Paisley UKWestCHEM, Department of Pure and Applied Chemistry Glasgow UKBackground Vibrational spectroscopy (VS) is a minimally invasive tool for analysing biological material to detect disease. This study aimed to review its application to human blood for cancer diagnosis. Methods A systematic review was undertaken using a keyword electronic database search (MEDLINE, Embase, PubMed, TRIP and Cochrane Library), with all original English‐language manuscripts examining the use of vibrational spectral analysis of human blood for cancer detection. Studies involving fewer than 75 patients in the cancer or control group, animal studies, or where the primary analyte was not blood were excluded. Results From 1446 results, six studies (published in 2010–2018) examining brain, bladder, oral, breast, oesophageal and hepatic cancer met the criteria for inclusion, with a total population of 2392 (1316 cancer, 1076 control; 1476 men, 916 women). For cancer detection, reported mean sensitivities in each included study ranged from 79·3 to 98 per cent, with specificities of 82·8–95 per cent and accuracies between 81·1 and 97·1 per cent. Heterogeneity in reporting strategies, methods and outcome measures made meta‐analysis inappropriate. Conclusion VS shows high potential for cancer diagnosis, but until there is agreement on uniform standard reporting methods and studies with adequate sample size for valid classification models have been performed, its value in clinical practice will remain uncertain.https://doi.org/10.1002/bjs5.50289 |
| spellingShingle | D. J. Anderson R. G. Anderson S. J. Moug M. J. Baker Liquid biopsy for cancer diagnosis using vibrational spectroscopy: systematic review BJS Open |
| title | Liquid biopsy for cancer diagnosis using vibrational spectroscopy: systematic review |
| title_full | Liquid biopsy for cancer diagnosis using vibrational spectroscopy: systematic review |
| title_fullStr | Liquid biopsy for cancer diagnosis using vibrational spectroscopy: systematic review |
| title_full_unstemmed | Liquid biopsy for cancer diagnosis using vibrational spectroscopy: systematic review |
| title_short | Liquid biopsy for cancer diagnosis using vibrational spectroscopy: systematic review |
| title_sort | liquid biopsy for cancer diagnosis using vibrational spectroscopy systematic review |
| url | https://doi.org/10.1002/bjs5.50289 |
| work_keys_str_mv | AT djanderson liquidbiopsyforcancerdiagnosisusingvibrationalspectroscopysystematicreview AT rganderson liquidbiopsyforcancerdiagnosisusingvibrationalspectroscopysystematicreview AT sjmoug liquidbiopsyforcancerdiagnosisusingvibrationalspectroscopysystematicreview AT mjbaker liquidbiopsyforcancerdiagnosisusingvibrationalspectroscopysystematicreview |